Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

CJC-1295 DAC Dosage & Reconstitution

CJC-1295 with drug affinity complex. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.

1Set Up Your Mix

2.5 mg/mL · 2500 mcg/mL

Your Answer — CJC-1295 DAC

5 mg in 2 mL
40Draw To This Line
0.4That's This Many mL
5Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 40
5 mg ÷ 2 mL = 2.5 mg/mL  →  1 mg ÷ 2.5 mg/mL = 0.4 mL  →  × 100 = 40 units
Looks good. Draw to 40 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 5 doses.
When to dose
Time of dayBefore bed, or first thing in the morning — not during the day.
FoodFasted. Nothing to eat for about 2 hours before, and wait 20–30 minutes after.

Food, and carbohydrate in particular, raises insulin and blunts the growth-hormone pulse these compounds are meant to trigger. The two windows where you are naturally fasted and GH release is highest are early sleep and first thing on waking, which is why those are the only two sensible times.

2Week-By-Week Plan — CJC-1295 DAC

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–4 1 mg once weekly 0.4 mL 40 u 4 4 mg
Week 5 onward
per 4 weeks from here on
2 mg once weekly 0.8 mL 80 u 4 8 mg
Time until the top dose
4 weeks
Peptide used getting there
4 mg
Vials you'll need
1 × 5 mg
Once you're at the top dose
8 mg / 4 wk · 1.6 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — CJC-1295 DAC

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Low reported 1 mg once weekly 0.4 mL 40 u 5 doses
Standard 2 mg once weekly 0.8 mL 80 u 2 doses
Trial dose30–60 mcg/kg weekly Set by body weight — can't be turned into a single amount to draw
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About CJC-1295 DAC

GH Secretagogue
Also known as
CJC-1295 with drug affinity complex
Class
GH Secretagogue
Route
Subcutaneous
Half-life
~6–8 days
Evidence tier
Clinical

GHRH analogue conjugated to bind serum albumin, extending half-life from minutes to days. This produces sustained GH/IGF-1 elevation rather than pulses — a meaningfully different physiological profile from the no-DAC version.

Buy CJC-1295 DAC

Common Questions — CJC-1295 DAC

How much bacteriostatic water do I add to a 5 mg vial of CJC-1295 DAC?

Adding 2 mL of bacteriostatic water to a 5 mg vial gives 2.5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of CJC-1295 DAC is used in research?

Published and reported figures for CJC-1295 DAC run from 1 mg to 2 mg, typically once weekly. This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 1 mg dose of CJC-1295 DAC?

At 2.5 mg/mL, a 1 mg dose is 40 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 5 doses.

How strong is the evidence behind these CJC-1295 DAC doses?

CJC-1295 DAC is graded clinical. Human trial or approved-label dosing has been published for this compound. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published
Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analogue of GHRH Teichman SL, et al. JCEM, 2006
The human dose-escalation study; source of the mcg/kg figures.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Other gh secretagogue peptides

Compounds in the same class, or browse the full catalogue.

CJC-1295 (no DAC)

A tetra-substituted GHRH(1-29) analogue without the drug affinity complex, giving a short pulse rather than sustained elevation. F…

GHRP-2

A growth hormone-releasing peptide with an approved diagnostic use in Japan for GH deficiency testing. Less receptor-selective tha…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.

Need this on one page to print, screenshot or send?

Make a dose card →